Related Experiment Video
Updated: May 5, 2026

05:00
Intense Pulsed Light for the Treatment of Dry Eye Owing to Meibomian Gland Dysfunction
Published on: April 1, 2019
15.1K
Intense Pulsed Light Combined with Low Level Blue and Red Light Therapy for Demodex-Associated Blepharitis
Sarah Farrant1, Giuseppe Giannaccare2, Chris Hong Long Lim3,4,5
1Earlam and Christopher Optometrists Ltd, Taunton, UK.
Clinical Ophthalmology (Auckland, N.Z.)
|August 12, 2025
Summary
This study shows that combining intense pulsed light (IPL) and low-level light therapy (LLLT) effectively treats Demodex-associated blepharitis. The combined therapy significantly improved ocular surface health and reduced patient symptoms without adverse effects.
Area of Science:
- Ophthalmology
- Dermatology
- Medical Technology
Background:
- Demodex-associated blepharitis is a prevalent chronic eyelid condition, often resistant to conventional treatments.
- Current therapeutic strategies lack a universal consensus on optimal efficacy for Demodex mite infestation.
- Ocular surface disease (OSD) frequently coexists with Demodex-associated blepharitis, complicating management.
Purpose of the Study:
- To evaluate the effectiveness of a combined intense pulsed light (IPL) and low-level light therapy (LLLT) approach.
- To assess the impact of this combined light therapy on Demodex-associated blepharitis.
- To determine the treatment's efficacy in improving associated ocular surface disease (OSD) and patient symptoms.
Main Methods:
- Retrospective analysis of medical records for patients with Demodex-associated blepharitis refractory to first-line treatments.
- Patients received a combination of IPL and LLLT (blue and red light exposure).
- Clinical parameters including collarettes, saponification, hyperemia, corneal staining, tear film stability, and patient-reported symptoms were assessed pre- and post-treatment.
Main Results:
- Significant reductions were observed in collarette scores (p=0.007) and saponification rates (p=0.002).
- Improvements noted in conjunctival hyperemia (p=0.005), corneal fluorescein staining (p=0.031), and tear film parameters.
- Patient-reported symptoms significantly improved (p=0.003) with no treatment-related adverse effects.
Conclusions:
- Combined IPL and LLLT offers an effective treatment strategy for recalcitrant Demodex-associated blepharitis.
- This therapeutic approach successfully reduces Demodex mite burden and enhances ocular surface parameters.
- The treatment improves patient symptoms and demonstrates a favorable safety profile.

